Skip to main content

Share story

Science

2 Deaths In China Reopen Gene Therapy Debates

2 Deaths In China Reopen Gene Therapy Debates Image: Primary
Two undisclosed deaths in China have reopened questions about transparency and oversight in gene therapy. The deaths occurred under China's investigator-initiated trial pathway, which allows hospitals to run experimental medicines without direct oversight from the National Medical Products Administration. The source states that the two most recent gene-editing deaths in China matter because they have reignited debate about safeguards and disclosure in the field.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Forbes and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Science
AI Science

Samsung reports faster chip simulations using AI and Nvidia GPUs

Samsung achieved a roughly 1,600x speedup in one chip engineering simulation by combining AI-predicted material properties, coarser computational grids and Nvidia GPU acceleration, Nvidia said.

AI Security
AI Security

AIM Intelligence integrates Starfort with Nvidia's agent security runtime

AIM Intelligence is integrating its Starfort agent control platform with Nvidia OpenShell to combine detection of malicious instructions and data leakage with runtime access controls, Nvidia announced. The integration targets employee productivity and enterprise workflows.